UHN patients given unlicensed drug that led to diabetes, liver dysfunction and one death, study finds
by from on (#4A05E)
According to new data, deferiprone, used to treat hereditary blood disorders such as thalassemia, poses serious health risks. And doctors say hospital administrators were told about the risks years ago.